Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Cell
|
July 1, 1985
B lymphocyte receptors and polyphosphoinositide degradation
M K Bijsterbosch, C J Meade, G A Turner, et al.
Journal of Lipid Mediators and Cell Signalling
|
May 1, 1994
Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation
C J Meade, F Birke, S Metcalfe, et al.
European Journal of Clinical Pharmacology
|
January 1, 1988
Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation
W S Adamus, H Heuer, C J Meade, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2001
In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist
F W Birke, C J Meade, R Anderskewitz, et al.
Clinical and Experimental Immunology
|
January 1, 1981
The relationship between hyperglycaemia and renal immune complex deposition in mice with inherited diabetes
C J Meade, D R Brandon, W Smith, et al.
Biochemical Pharmacology
|
January 15, 1984
gamma-Hexachlorocyclohexane stimulation of macrophage phospholipid hydrolysis and leukotriene production
C J Meade, J Harvey, J R Boot, et al.
Lancet (London, England)
|
October 19, 1991
Serum PAF acetylhydrolase and chronic cholestasis
C J Meade, S Metcalfe, R Svvennsen, et al.
The European Respiratory Journal
|
December 22, 1999
Epinastine (WAL 801CL) inhibits the electrical field stimulation-induced cholinergic contraction in guinea pig and human airways in vitro
L J Dupont, J L Pype, C J Meade, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Cell
|
July 1, 1985
B lymphocyte receptors and polyphosphoinositide degradation
M K Bijsterbosch, C J Meade, G A Turner, et al.
Journal of Lipid Mediators and Cell Signalling
|
May 1, 1994
Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation
C J Meade, F Birke, S Metcalfe, et al.
European Journal of Clinical Pharmacology
|
January 1, 1988
Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation
W S Adamus, H Heuer, C J Meade, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2001
In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist
F W Birke, C J Meade, R Anderskewitz, et al.
Clinical and Experimental Immunology
|
January 1, 1981
The relationship between hyperglycaemia and renal immune complex deposition in mice with inherited diabetes
C J Meade, D R Brandon, W Smith, et al.
Biochemical Pharmacology
|
January 15, 1984
gamma-Hexachlorocyclohexane stimulation of macrophage phospholipid hydrolysis and leukotriene production
C J Meade, J Harvey, J R Boot, et al.
Lancet (London, England)
|
October 19, 1991
Serum PAF acetylhydrolase and chronic cholestasis
C J Meade, S Metcalfe, R Svvennsen, et al.
The European Respiratory Journal
|
December 22, 1999
Epinastine (WAL 801CL) inhibits the electrical field stimulation-induced cholinergic contraction in guinea pig and human airways in vitro
L J Dupont, J L Pype, C J Meade, et al.
Page
of 5